Anticoagulant effect at the time of epidural catheter removal in patients receiving twice-daily or once-daily low-molecular-weight heparin and continuous epidural analgesia after orthopedic surgery

Thrombosis and Haemostasis

Volumn 88, Issue 1, 2002, Pages 37-40

  Douketis, James D ^a   Kinnon, Krystyna ^a   Crowther, Mark A ^a  

^a ST JOSEPH S HOSPITAL   (Canada)

Author keywords

Bleeding; Epidural analgesia; Low molecular weight heparin; Thrombosis

Indexed keywords

ANALGESIC AGENT; ANTIBODY; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 10A ANTIBODY; BUPIVACAINE; DALTEPARIN; ENOXAPARIN; FENTANYL; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; UNCLASSIFIED DRUG; BLOOD CLOTTING FACTOR 10;

AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTINUOUS EPIDURAL ANESTHESIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; EPIDURAL CATHETER; EPIDURAL HEMATOMA; EUROPE; HEALTH CARE QUALITY; HIP DISEASE; HUMAN; KNEE ARTHROPLASTY; KNEE DISEASE; MALE; MEASUREMENT; MEDICAL AUDIT; MEDICAL PRACTICE; NORTH AMERICA; ORTHOPEDIC SURGERY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; THROMBOSIS; TOTAL HIP PROSTHESIS; TREATMENT PLANNING; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG COMBINATION; EPIDURAL ANESTHESIA; FEMALE; INDWELLING CATHETER; METHODOLOGY; MIDDLE AGED; POSTOPERATIVE CARE;

AGED; ANALGESIA, EPIDURAL; CATHETERS, INDWELLING; COHORT STUDIES; DALTEPARIN; DRUG THERAPY, COMBINATION; ENOXAPARIN; FACTOR X; FEMALE; HEMATOMA, EPIDURAL, CRANIAL; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; ORTHOPEDIC PROCEDURES; POSTOPERATIVE CARE; PROSPECTIVE STUDIES;

EID: 0036301786     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613150     Document Type: Article

References (21)

1. Anticoagulants and spinal-epidural anesthesia
2. Low molecular weight heparin: Biochemistry, pharmacology, perioperative prophylaxis regimens, and guidelines or regional anesthetic management
3. Prevention of venous thromboembolism
4. Effects of intravenous patient-controlled analgesia with morphine, continuous epidural analgesia, and continuous three-in-one-block on postoperative pain and knee rehabilitation after unilateral total knee arthroplasty
5. FDA public health advisory: Reports of epidural or spinal hematomas with the concurrent use of low molecular weight heparin and spinal/epidural anesthesia or spinal puncture
6. Neuraxial block and low-molecular-weight heparin: Balancing perioperative prophylaxis regimens, and guidelines for regional anesthetic management
7. Central neuraxial block and low molecular weight heparin (enoxaparin): Lessons learned from two different dosage regimens in two continents
8. The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacement
9. The antithrombotic activity and pharmacokinetics of enoxaparine, a low molecular weight heparin, in humans given single subcutaneous doses 20 to 80 mg
10. Aging and venous thromboembolism influence the pharmacodynamics of the anti-factor Xa and anti-thrombin activities of a low-molecular weight heparin (nadroparin)
11. Comparison of the pharmacokinetic profiles of three low molecular weight heparins - Dalteparin, enoxaparin, nadroparin - Administered subcutaneously in healthy volunteers (doses for prevention of thromboembolism)
12. A comparative study of three low-molecular-weight heparins (LMWH) and unfractionated heparin (UH) in healthy volunteers
13. Heparin and low-molecular-weight heparin: Mechanism of action, pharmacokinetics, dosing, monitoring, efficacy, safety
14. Low molecular weight heparin and neuraxial anesthesia
15. Statistics: Detecting a rare adverse drug reaction using spontaneous reports
16. Surgical management of spinal epidural hematoma: Relationship between surgical timing and neurological outcome
17. Timing of initial administration of low-molecular weight heparin prophylaxis against deep vein thrombosis in patients following hip arthroplasty
18. Effects of peropoperative analgesic technique on the surgical outcome and duration of rehabilitation after major knee surgery
19. Herparine et anesthesies medullaires: Analyse de decision
20. Prediction of creatinine clearance from serum creatinine